sibo solutions · 2018-08-31 · • nattokinase nsk-sd blend and serratiopeptidase – vascular...
TRANSCRIPT
Functional & Integrative Medicine Ltd, 77 Austin St, PO Box 19033, Onekawa, Napier 4146 NZPh 0800 439 633 Fax 0800 439 630 [email protected] www.fxmed.co.nz
Based on the Treatment Strategies provided by Sharon Erdrich MHSc [Hons], NZRGON, Dip Nat, Dip Med Herb.
SIBO Seminar 2017
SIBO SOLUTIONSFxMed Booklet
CONTENTSProduct
Treatment Objectives Chart
Atrantil — KBS Research
Berbercap — Thorne Research
Berberine-500 — Thorne Research
Betaine HCL/Pepsin — Thorne Research
Bio-Gest — Thorne Research
Candicidal — Xymogen
Critical Digestion — Enzyme Science
Curcumin — Ayush Herbs
EnteroMend — Thorne Research
Enzyme Defense Pro — Enzyme Science
Happy Belly — Metabolic Maintenance
MotilPro — Pure Encapsulations
NAC — Pure Encapsulations
Neem Plus — Ayush Herbs
Prescript-Assist Pro — Researched Nutritionals
Sacro-B — Thorne Research
Functional Testing for SIBO
Page
2
33334445556667778
Trea
tmen
t Obj
ectiv
es C
hart
Atra
ntil
Berb
erca
pBe
rber
ine-
500
Beta
ine
HCl &
Pe
psin
Bio-
Gest
Cand
icid
alCr
itica
l Di
gesti
onCu
rcum
inEn
tero
Men
dEn
zym
e De
fens
e Pr
o
Happ
y Be
llyM
otilP
roN
ACN
eem
Pl
usPr
escr
ipt
Assis
t Pro
Sacr
o-B
Erad
icat
e th
e Ba
cter
ial O
verg
row
th
(Met
hano
geni
c Ba
cter
ia)
X
Erad
icat
e th
e Ba
cter
ial
Ove
rgro
wth
(Hyd
roge
nic
Bact
eria
)X
XX
XX
Disr
upt t
he B
iofil
ms
XX
XX
XX
Addr
ess U
nder
lyin
g Fa
ctor
s (hy
poch
lorh
ydria
)X
XX
Addr
ess U
nder
lyin
g Fa
ctor
s (Li
ver/
Bile
flow
)X
Enha
nce
Gut M
otilit
yX
Rest
ore
Gut I
nteg
rity
X
Rest
ore
Gut F
lora
XX
2.
Berbercap (200mg) – Broad-spectrum immune and GI activity
• Helps maintain a healthy immune response.• Helps maintain the body’s normal intestinal flora.• Biofilm disruptor activity.• Eradicate bacterial overgrowth – hydrogenic bacteria.• Promotes healthy respiratory mucus membranes.
Berberine-500 – Supports a healthy balance of normal bacteria in the intestines.
• Anti-microbial effect against bacteria, fungi, viruses, yeast, protozoans and helminthes.
• Biofilm disruptor activity.• Eradicate bacterial overgrowth – hydrogenic bacteria.• Higher amount for maintenance of healthy glucose
metabolism.• Supports healthy lipid levels.• Provides cardiovascular support.• Contains 500mg of Berberine HCl per capsule.
Atrantil — NEW!– Daily support and balance for the digestive system
A patented nutraceutical and a vital component of any Methanogenic SIBO Protocol, this product facilitates the elimination of unwanted methane producing bacteria from the small intestine that can cause bloating, abdominal discomfort and changes in bowel habits. Atrantil works by calming the gut with M. Balsamea Willd extract (peppermint), then Quebracho extract (flavonoid) binds to the hydrogen that the bacteria use as fuel to produce methane gas. The Conker Tree saponins (natural antibacterial) also reduce abundant methane by binding to the reductase enzyme in the weakened archaebacteria – stopping methane production.
• These 3 active ingredients work synergistically to reduce the incidence of bloating, abdominal discomfort and changing bowel habits (constipation & diarrhoea) either due to SIBO or the consumption of gas forming foods.
• Atrantíl can increase cellular support to promote a healthy gut.
• New research shows that the problems start with methane producing archaebacteria. When left untreated, these out-of-place bacteria feed off the foods you eat and create methane gas, this leaves you bloated and uncomfortable. Atrantíl breaks the cycle naturally restoring good digestion.
3.
Betaine HCl & Pepsin – For improved protein digestion
• For optimal stomach acidity.• Promotes protein breakdown and absorption.• Benefits individuals with occasional indigestion.• Thorne provides hydrochloric acid and pure pepsin from a
porcine source, which is pure, undiluted and lactose-free.
Bio-Gest – Broad spectrum digestive aid
• For individuals needing more than HCI – a blend of hydrochloric acid (HCI), pepsin, pancreatin and ox bile.
• Promotes digestion of proteins, carbohydrates, and fats.• Ox bile added to promote fat digestion.• Benefits individuals with occasional indigestion.
Critical Digestion - High potency digestive enzyme formula
Enzyme supplementation works with our digestion to lessen symptoms associated with impaired digestion. Contains patented Thera-blendTM enzymes: multiple strains of enzymes that work in various pH levels and demonstrate unmatched performance and speed in digestion of proteins, fats, fibers and carbohydrates in addition to promoting an optimally functional GI tract.
• High potency formula comprised of digestive enzyme, probiotics and nutraceuticals.
• Soothes occasional indigestion, gas and bloating.• Supports nutrient absorption and also improves HCL
availability in the upper GI.• 1 billion active probiotic cultures per capsule.• Vegetarian enzyme.
4.
Candicidal– Natural Support for GI Balance
The complementary blend of ingredients is formulated to support against microbial insult, support gastrointestinal function, and moderate oxidative and inflammatory activities. Contains Origanox™ WS, phenolic-rich ingredient extracted from the edible herb Oregano ‘Origanum vulgare, as well as herbs to support digestion and a healthy GI system.
• Supports healthy microbial balance.• Supports gastrointestinal health.• Provides nutrients that support antioxidant and anti-
inflammatory activity.• Eradicate bacterial overgrowth – hydrogenic bacteria.
5.
Curcumin – A potent herbal anti-inflammatory and powerful antioxidant.
Curcuma longa (Turmeric) has a long history of use in Ayurvedic medicine as a treatment for inflammatory conditions.
• Anti-biofilm activity.• Supports a healthy inflammatory and metabolic response
already within a normal range. • It is known to have important antioxidant properties, to
support the body’s natural detoxification and liver function, and to support healthy brain tissue.
• Best in combination with NAC for treatment of SIBO.
Enzyme Defense Pro – Proteolytic enzymes to support healthy immune function
• High potency proteolytic enzymes targeting cells that are dead, damaged or do not belong.
• Has shown to help disrupt biofilm formation.• Critical support for immune health.• Nattokinase NSK-SD blend and Serratiopeptidase – vascular
and circulatory health.• Includes Vitamin D3 and L-Lysine.
EnteroMend – Intestinal Health Support
A unique formula combining the mucosa-protective effects of L-Glutamine with highly absorbable botanical complexes to provide a great-tasting orange-vanilla powder for maintenance of a healthy intestinal tract.
• Meriva® and Casperome® (curcumin and Boswellia phytosomes) – enhanced absorption and to help maintain an already healthy inflammatory response in the GI tract.
• DaltonMax 700® – a unique 200:1 – potency aloe extract that soothes the mucus membranes of the GI tract.
• Sunfiber® – promotes healthy flora, butyrate levels and bowel regularity.
• L-Glutamine – provides fuel for the cells of the intestines for support of colonic permeability.
6.
MotilPro – Promotes GI motility
An advanced gut signalling support formula, supporting serotonergic and cholinergic neurotransmission in the GI tract, as serotonin and acetylcholine are the principal neurotransmitters that stimulate GI motility.
• 5HTP and Activated B6 – stimulates enteric neurons through activation of 5HT4 receptors.
• Acetyl-l-carnitine – supports autonomic neuronal health and encourages neurotransmission of signals to encourage healthy motility.
• Ginger – modulates serotonin signalling, supports gastric emptying, intestinal transit, healthy visceral sensation and upper GI comfort.
Happy Belly – To reduce harmful microbes and parasites
Happy Belly provide a variety of pharmacological actions that help to resolve dysbiosis and improve GI health. Caprylic acid, berberine, black walnut, garlic, and olive leaf have shown antibacterial, antimicrobial, antifungal, anti-parasitic, antiviral, anti-diarrhoeal activities as well as beneficial effects on the GI tract and metabolism of the host. • Multiple modes of action thereby showing synergism,
biofilm disruption, and are less likely to cultivate resistance in pathogenic organisms.
• Integrative and functional medical practitioners can use Happy Belly as part of an antimicrobial regimen protocol for gastrointestinal repair.
• The proprietary blend of herbs has shown a long history of human medicinal use suggests low risk of adverse side effects and may be used alone or in conjunction with prescription antibiotics or antifungals.
• Recommended for the treatment of microbial imbalance, yeast overgrowth and parasites.
NAC – Liver support, detoxification and immune support
N-Acetyl-l-Cysteine (NAC) is a sulphur-containing amino acid, and is the precursor of the amino acids L-cysteine and glutathione.
• Powerful free radical scavengers.• Mucolytic action as well as providing powerful nutritional
support to cells as an antioxidant.• Inhabits biofilm formation and destroys developed biofilm.• Enhances glutathione production and plays a role in heavy
metal detoxification.• Effective in promoting normal liver detoxification.
Neem Plus – Immune and Skin Support
Has shown anti-biotic, anti-viral, anti-fungal and anti-bacterial properties, which supports the immune system and promotes healthy skin.
• Contains Azadirachta indica (Neem) – immune promoting properties.
• Emblica officinalis (Amla) – Antioxidant and adapatogenic properties.
• Tinospora cordifolia and Rubia cordifolia – immuno-supportive effects.
• Terminalia chebula (Haritaki) – mild laxative for occasional constipation and digestive aid properties.
• Terminalia belerica – digestive and liver support.• Eradicate bacterial overgrowth – hydrogenic bacteria.
Prescript – Assist Pro – Broad spectrum probiotic
High potency, clinically researched probiotic containing 30 plus soil based probiotics. These probiotics found in the soil were naturally available in our diet before our current farming techniques including pesticides, herbicides and other chemicals.
• Promotes a healthy response to gut-related issues and provides beneficial bacteria during prolonged antibiotic treatment.
• pH resistant micro flora.• Vegan, dairy free, does not require refrigeration.
Sacro-B – Beneficial yeast for the GI Tract
• Supports growth of beneficial intestinal flora.• Increases secretory IgA (sIgA) the body’s first line of defense
in the GI tract. • Enhances gut immunity and helpful for occasional diarrhea.• Numerous studies show Saccharomyces boulardii supports
the gastrointestinal system.
7.
The Comprehensive Stool Analysis (CSA) with Parasitology by Doctors Data Inc.
A non-invasive diagnostic assessment that helps pinpoint the causes of GI symptoms and chronic systemic conditions, and measures key markers of digestion, absorption and inflammation. It allows practitioners to evaluate the status of beneficial and imbalanced commensal bacteria, pathogenic bacteria, yeast/fungus and parasites (worms, eggs, larva and protozoa (including Giardia and Cryptosporidium). In relation to SIBO the CSA test - bacteriology culture will show a good indication of large intestine bacterial population. Also shows markers for fat malabsorption which often results from SIBO +/- low grade inflammation.It measures the following:
• Elastase (pancreatic exocrine sufficiency), fat, muscle and vegetable fibers, and carbohydrates — giving important information regarding the efficiency of digestion and absorption.
• Biomarkers such as lysozyme, lactoferrin, calprotectin, WBC’s and mucus. These markers can be used to differentiate between inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS). Lactoferrin is only markedly elevated prior to and during the active phases of IBD, but not with IBS. Monitoring fecal lactoferrin levels in patients with IBD can therefore facilitate timely treatment of IBD.
• Secretory IgA (sIgA) — the only bona fide marker of humoral immune status in the GI tract. sIgA is normally present in the GI tract, where it prevents binding of pathogens and antigens to the mucosal membrane, therefore it is essential to know the status of sIgA in the gut.
• RBC’s — may be associated with a parasitic / bacterial infection or inflammatory condition such as Ulcerative Colitis / Colorectal Cancer / Anal fistulas / Haemorrhoids.
• Occult Blood — Free haemoglobin (released when RBC’s are lysed).• pH is largely dependent on the fermentation of fibre by the beneficial flora of the gut (Short chain fatty acids).
A low pH makes the environment unsuitable for pathogens including bacteria and yeast.• Yeast — Indicates the presence of fungi such as Candida albicans. • Comprehensive Parasitology x 3 (3 day collection) considered the ‘gold standard’ by Gastro-Enterologists.
• Also available is the Comprehensive Stool Analysis (CSA) which tests the same species and intestinal biomarkers as the ‘CSA with Parasitology’, but without detecting parasites.
• Practitioners can also order just ‘Parasitology’ (without the ‘comprehensive’) which does not report other flora – useful as a re-test if only parasites were the issue.
LAB #: F000000-0000-0PATIENT: Sample PatientID: P0000000000 Doctor's Data, Inc.SEX: MaleDOB: AGE: 4
CLIENT #: 12345DOCTOR:
3755 Illinois Ave.St. Charles, IL 60174 U.S.A.Comprehensive Stool Analysis / Parasitology x3
SHORT CHAIN FATTY ACIDSWithin Outside Reference Range
% Acetate 5140 - 75 %
% Propionate 259 - 29 %
% Butyrate 209 - 37 %
% Valerate 4.60.5 - 7 %
Butyrate2.0
0.8 - 4.8 mg/mLTotal SCFA’s 9.9
4 - 18 mg/mL
INTESTINAL HEALTH MARKERSWithin Outside Reference Range
Red Blood Cells NoneNone - Rare
pH7.0
6 - 7.8 Occult Blood Neg
Neg
MACROSCOPIC APPEARANCEAppearance Expected
ColorBrown
BrownConsistency Soft Formed/Soft
©DOCTOR’S DATA, INC. ADDRESS: 3755 Illinois Avenue, St. Charles, IL 60174-2420 CLIA ID NO: 14D0646470 MEDICARE PROVIDER NO: 148453
0001953
Short chain fatty acids (SCFAs): SCFAs arethe end product of the bacterial fermentationprocess of dietary fiber by beneficial flora in thegut and play an important role in the health of theGI as well as protecting against intestinaldysbiosis. Lactobacilli and bifidobacteria producelarge amounts of short chain fatty acids, whichdecrease the pH of the intestines and thereforemake the environment unsuitable for pathogens,including bacteria and yeast. Studies have shownthat SCFAs have numerous implications inmaintaining gut physiology. SCFAs decreaseinflammation, stimulate healing, and contribute tonormal cell metabolism and differentiation. Levelsof Butyrate and Total SCFA in mg/mL areimportant for assessing overall SCFA production,and are reflective of beneficial flora levels and/oradequate fiber intake.
Red Blood Cells (RBC) in the stool may beassociated with a parasitic or bacterial infection,or an inflammatory bowel condition such asulcerative colitis. Colorectal cancer, anal fistulas,and hemorrhoids should also be ruled out.pH: Fecal pH is largely dependent on thefermentation of fiber by the beneficial flora of thegut.Occult blood: A positive occult blood indicatesthe presence of free hemoglobin found in thestool, which is released when red blood cells arelysed.
Color: Stool is normally brown because ofpigments formed by bacteria acting on bileintroduced into the digestive system from theliver. While certain conditions can causechanges in stool color, many changes areharmless and are caused by pigments in foodsor dietary supplements. Consistency: Stoolnormally contains about 75% water and ideallyshould be formed and soft. Stool consistencycan vary based upon transit time and waterabsorption.
LAB #: F000000-0000-0PATIENT: Sample PatientID: P0000000000 Doctor's Data, Inc.SEX: MaleDOB: AGE: 4
CLIENT #: 12345DOCTOR:
3755 Illinois Ave.St. Charles, IL 60174 U.S.A.
Comprehensive Stool Analysis / Parasitology x3
DIGESTION /ABSORPTION
Within Outside Reference Range
Elastase 440 > 200 µg/mL
Fat Stain Few None - Mod
Muscle fibers None None - Rare
Vegetable fibers Rare None - Few
Carbohydrates Neg Neg
INFLAMMATION
Within Outside Reference Range
Lactoferrin 2.6 < 7.3 µg/mL
Calprotectin* 68 10 - 50 µg/g
Lysozyme* 271 <= 600 ng/mL
White Blood Cells None None - Rare
Mucus Neg Neg
IMMUNOLOGY
Within Outside Reference Range
Secretory IgA* 39.7 51 - 204 mg/dL
Comments:
Date Collected: 01/28/2015 *For Research Use Only. Not for use in diagnostic procedures.Date Received: 01/30/2015 Methodology: Elisa, Microscopy, Colormetric,Date Completed: 02/06/2015 Gas Chromotography, ph Electrode©DOCTOR’S DATA, INC. ADDRESS: 3755 Illinois Avenue, St. Charles, IL 60174-2420 CLIA ID NO: 14D0646470 MEDICARE PROVIDER NO: 1484530001953
Elastase findings can be used for the diagnosisor the exclusion of exocrine pancreaticinsufficiency. Correlations between low levelsand chronic pancreatitis and cancer have beenreported. Fat Stain: Microscopic determinationof fecal fat using Sudan IV staining is aqualitative procedure utilized to assess fatabsorption and to detect steatorrhea. Musclefibers in the stool are an indicator of incompletedigestion. Bloating, flatulence, feelings of“fullness” may be associated with increase inmuscle fibers. Vegetable fibers in the stool maybe indicative of inadequate chewing, or eating“on the run”. Carbohydrates: The presence ofreducing substances in stool specimens canindicate carbohydrate malabsorption.
Lactoferrin and Calprotectin are reliablemarkers for differentiating organic inflammation(IBD) from function symptoms (IBS) and formanagement of IBD. Monitoring levels of fecallactoferrin and calprotectin can play an essentialrole in determining the effectiveness of therapy,are good predictors of IBD remission, and canindicate a low risk of relapse. Lysozyme* is anenzyme secreted at the site of inflammation inthe GI tract and elevated levels have beenidentified in IBD patients. White Blood Cells(WBC) and Mucus in the stool can occur withbacterial and parasitic infections, with mucosalirritation, and inflammatory bowel diseases suchas Crohn’s disease or ulcerative colitis.
Secretory IgA* (sIgA) is secreted by mucosaltissue and represents the first line of defense ofthe GI mucosa and is central to the normalfunction of the GI tract as an immune barrier.Elevated levels of sIgA have been associatedwith an upregulated immune response.
LAB #: F000000-0000-0
PATIENT: Sample Patient
ID: P0000000000 Doctor's Data, Inc.
SEX: MaleDOB: AGE: 4
CLIENT #: 12345DOCTOR:
3755 Illnois Ave.St. Charles, IL 60174 U.S.A.
Comprehensive Stool Analysis / Parasitology x3
PARASITOLOGY/MICROSCOPY *PARASITOLOGY INFORMATION
Sample 1
None Ova or Parasites
Sample 2
None Ova or Parasites
Sample 3
None Ova or Parasites
GIARDIA/CRYPTOSPORIDIUM IMMUNOASSAY
Within Outside Reference Range
Giardia intestinalis Neg Neg
Cryptosporidium Neg Neg
Comments:
Date Collected: 01/28/2015
Date Received: 01/30/2015
Date Completed: 02/06/2015
©DOCTOR’S DATA, INC. ADDRESS: 3755 Illinois Avenue, St. Charles, IL 60174-2420 CLIA ID NO: 14D0646470 MEDICARE PROVIDER NO: 148453
0001794
Intestinal parasites are abnormal inhabitants of the gastrointestinal tract that
have the potential to cause damage to their host. The presence of any parasite
within the intestine generally confirms that the patient has acquired the
organism through fecal-oral contamination. Damage to the host includes
parasitic burden, migration, blockage and pressure. Immunologic inflammation,
hypersensitivity reactions and cytotoxicity also play a large role in the morbidity
of these diseases. The infective dose often relates to severity of the disease
and repeat encounters can be additive.
There are two main classes of intestinal parasites, they include protozoa and
helminths. The protozoa typically have two stages; the trophozoite stage that is
the metabolically active, invasive stage and the cyst stage, which is the
vegetative inactive form resistant to unfavorable environmental conditions
outside the human host. Helminths are large, multicellular organisms. Like
protozoa, helminths can be either free-living or parasitic in nature. In their adult
form, helminths cannot multiply in humans.
In general, acute manifestations of parasitic infection may involve diarrhea with
or without mucus and or blood, fever, nausea, or abdominal pain. However
these symptoms do not always occur. Consequently, parasitic infections may
not be diagnosed or eradicated. If left untreated, chronic parasitic infections
can cause damage to the intestinal lining and can be an unsuspected cause of
illness and fatigue. Chronic parasitic infections can also be associated with
increased intestinal permeability, irritable bowel syndrome, irregular bowel
movements, malabsorption, gastritis or indigestion, skin disorders, joint pain,
allergic reactions, and decreased immune function.
In some instances, parasites may enter the circulation and travel to various
organs causing severe organ diseases such as liver abscesses and
cysticercosis. In addition, some larval migration can cause pneumonia and in
rare cases hyper infection syndrome with large numbers of larvae being
produced and found in every tissue of the body.
One negative parasitology x1 specimen does not rule out the possibility of
parasitic disease, parasitology x3 is recommended. This exam is not designed
to detect Cryptosporidium spp, Cyclospora cayetanensis or Microsproridia spp.
Giardia intestinalis (lamblia) is a protozoan that
infects the small intestine and is passed in stool
and spread by the fecal-oral route. Waterborne
transmission is the major source of giardiasis.
Cryptosporidium is a coccidian protozoa that
can be spread from direct person-to-person
contact or waterborne transmission.
*A trichrome stain and concentrated iodine wet
mount slide is read for each sample submitted.
LAB #: F000000-0000-0
PATIENT: Sample Patient
ID: P0000000000
Doctor's Data, Inc.
SEX: Male
DOB: AGE: 4
CLIENT #: 12345
DOCTOR:
3755 Illinois Ave.
St. Charles, IL 60174 U.S.A.
Comprehensive Stool Analysis / Parasitology x3
BACTERIOLOGY CULTURE
Expected/Beneficial floraCommensal (Imbalanced) flora
Dysbiotic flora
3+ Bacteroides fragilis group1+ Beta strep, not group A or B
4+ Bifidobacterium spp.2+ Citrobacter freundii complex
NG Escherichia coli1+ Citrobacter freundii complex,isolate 2
NG Lactobacillus spp.2+ Enterobacter cloacae complex
NG Enterococcus spp.3+ Gamma hemolytic strep
1+ Staphylococcus aureus
NG Clostridium spp.
NG = No Growth BACTERIA INFORMATION
YEAST CULTURE
Normal flora
Dysbiotic flora
No yeast isolated
MICROSCOPIC YEAST
YEAST INFORMATION
Result: Expected:
None None - Rare
Comments:
Date Collected: 01/28/2015
Date Received: 01/30/2015
Date Completed: 02/06/2015
©DOCTOR’S DATA, INC. ADDRESS: 3755 Illinois Avenue, St. Charles, IL 60174-2420 CLIA ID NO: 14D0646470 MEDICARE PROVIDER NO: 148453
0001793
Expected /Beneficial bacteria make up a significant portion of the total microflora in a healthy & balanced GI tract. These beneficial bacteria have many
health-protecting effects in the GI tract including manufacturing vitamins, fermenting fibers, digesting proteins and carbohydrates, and propagating anti-
tumor and anti-inflammatory factors.
Clostridia are prevalent flora in a healthy intestine. Clostridium spp. should be considered in the context of balance with other expected/beneficial flora.
Absence of clostridia or over abundance relative to other expected/beneficial flora indicates bacterial imbalance. If C. difficile associated disease is
suspected, a Comprehensive Clostridium culture or toxigenic C. difficile DNA test is recommended.
Commensal (Imbalanced) bacteria are usually neither pathogenic nor beneficial to the host GI tract. Imbalances can occur when there are insufficient
levels of beneficial bacteria and increased levels of commensal bacteria. Certain commensal bacteria are reported as dysbiotic at higher levels.
Dysbiotic bacteria consist of known pathogenic bacteria and those that have the potential to cause disease in the GI tract. They can be present due to a
number of factors including: consumption of contaminated water or food, exposure to chemicals that are toxic to beneficial bacteria; the use of antibiotics,
oral contraceptives or other medications; poor fiber intake and high stress levels.
Yeast normally can be found in small quantities in the skin, mouth, intestine and mucocutaneous
junctions. Overgrowth of yeast can infect virtually every organ system, leading to an extensive array
of clinical manifestations. Fungal diarrhea is associated with broad-spectrum antibiotics or
alterations of the patient’s immune status. Symptoms may include abdominal pain, cramping and
irritation. When investigating the presence of yeast, disparity may exist between culturing and
microscopic examination. Yeast are not uniformly dispersed throughout the stool, this may lead to
undetectable or low levels of yeast identified by microscopy, despite a cultured amount of yeast.
Conversely, microscopic examination may reveal a significant amount of yeast present, but no yeast
cultured. Yeast does not always survive transit through the intestines rendering it unvialble.
The microscopic finding of yeast in the stool is
helpful in identifying whether there is
proliferation of yeast. Rare yeast may be
normal; however, yeast observed in higher
amounts (few, moderate, or many) is abnormal.
* Aeromonas, Campylobacter, Plesiomonas, Salmonella,
Shigella, Vibrio, Yersinia, & Edwardsiella tarda have
been specifically tested for and found absent unless
reported.
8.
Functional Testing for SIBO
For additional information, please request FxMed’s Functional Testing Reference Catalogue or contact FxMed’s Technical Support Team to book in a skype training on either of these tests on 0800 439 633 or [email protected]
9.
Organic Acids Test (OAT) by The Great Plains Laboratory
The Organic Acids Test (OAT) measures organic acids in a urine sample. It offers a comprehensive metabolic snapshot of a patient’s overall health. The test includes 70 metabolite markers that can be very useful for discovering underlying causes of chronic illness. It provides a unique profile into:
• Intestinal Microbial overgrowth (yeast and fungal markers, bacterial and clostridia bacteria markers).• Cellular energy status, neurotransmitter metabolism, nutrient deficiencies and detoxification. • In regards to SIBO provides information of bacterial overgrowth indicated by levels of hippurate,
4-Hydroxybenzoic, and other bacterial metabolites.
The Great Plains Laboratory, Inc.Requisition #:
Patient Name: Physician:
Date of Collection: 4/21/2015
Indicator of Fluid Intake
89
76
mg/dL
*Creatinine
*The creatinine test is performed to adjust metabolic marker results for differences in fluid intake. Urinary creatinine has
limited diagnostic value due to variability as a result of recent fluid intake. Samples are rejected if creatinine is below 20
mg/dL unless the client requests results knowing of our rejection criteria.
Example of Elevated Value
Explanation of Report FormatThe reference ranges for organic acids were established using samples collected from typical individuals of all ages with no known
physiological or psychological disorders. The ranges were determined by calculating the mean and standard deviation (SD) and
are defined as + 2SD of the mean. Reference ranges are age and gender specific, consisting of Male Adult (>13 years), Female
Adult (>13 years), Male Child (<13 years), and Female Child (<13 years).There are two types of graphical representations of patient values found in the new report format of both the standard Organic
Acids Test and the Microbial Organic Acids Test. The first graph will occur when the value of the patient is within the reference (normal) range, defined as the mean plus or minus
two standard deviations.
The second graph will occur when the value of the patient exceeds the upper limit of normal. In such cases, the graphical
reference range is “shrunk” so that the degree of abnormality can be appreciated at a glance. In this case, the lower limits of
normal are not shown, only the upper limit of normal is shown.In both cases, the value of the patient is given to the left of the graph and is repeated on the graph inside a diamond. If the value
is within the normal range, the diamond will be outlined in black. If the value is high or low, the diamond will be outlined in red. Example of Value Within Reference Range
Organic Acids Test - Nutritional and Metabolic Profile Page 5 of 10
The Great Plains Laboratory, Inc.Requisition #:
Patient Name: Physician:
Date of Collection: 4/21/2015
Metabolic Markers in Urine
Reference Population - Females Age 13 and Over
(mmol/mol creatinine)Patient Value
Reference Range
Indicators of DetoxificationGlutathione
23-
58
3310
23
Pyroglutamic ä
3.0- H
59
1.80.03
3.0
2-Hydroxybutyric ä
Ammonia Excess
0.33-
60
0.540.06
0.33
Orotic
Aspartame, salicylates, or GI bacteria
1.5≤ H
61
1.3
1.5
2-Hydroxyhippuric
ä A high value for this marker may indicate a Glutathione deficiency. Amino Acid Metabolites
0≤
62
0.420.00
2-Hydroxyisovaleric
0.40≤
63
2.1
0.40
2-Oxoisovaleric
0.49≤
64
0.87
0.49
3-Methyl-2-oxovaleric
0≤
65
0.480.00
2-Hydroxyisocaproic
0.47≤ H
66
0.37
0.47
2-Oxoisocaproic
0.10≤
67
0.16
0.10
2-Oxo-4-methiolbutyric
0.18≤
68
0.21
0.18
Mandelic
0.17≤
69
0.20
0.17
Phenyllactic
0.48-
70
1.90.20
0.48
Phenylpyruvic
0.04≤
71
0.360.04
Homogentisic
0.72≤
72
0.80
0.72
4-Hydroxyphenyllactic
1.5≤
73
3.0
1.5
N-Acetylaspartic
3.0≤
74
9.7
3.0
Malonic
Mineral Metabolism
2 638-
75
5 0001 000
2638
Phosphoric
Organic Acids Test - Nutritional and Metabolic Profile Page 4 of 10
The Great Plains Laboratory, Inc.
Requisition #:
Patient Name:
Physician:
Date of Collection: 4/21/2015
Metabolic Markers in Urine Reference Population - Females Age 13 and Over (mmol/mol creatinine)
Patient
Value
Reference Range
Pyrimidine Metabolites - Folate Metabolism
5.1≤40 9.7 5.1Uracil
0.22≤41 0.56 0.22Thymine
Ketone and Fatty Acid Oxidation
19≤ H42 3.1 193-Hydroxybutyric
9.5≤43 10 9.5Acetoacetic
0.34≤44 4.8 0.344-Hydroxybutyric
1.4-45 2.80.44 1.4Ethylmalonic
2.1-46 2.20.10 2.1Methylsuccinic
2.0-47 3.80.04 2.0Adipic
0.80-48 2.20.18 0.80Suberic
0.19≤49 0.24 0.19Sebacic
Nutritional Markers
Vitamin B12
2.0≤50 2.3 2.0Methylmalonic ä
Vitamin B6
5.1≤51 34 5.1Pyridoxic (B6)
Vitamin B5
1.3≤52 10 1.3Pantothenic (B5)
Vitamin B2 (Riboflavin)
0.29-53 0.360.04 0.29Glutaric ä
Vitamin C
0.44- L54 20010 0.44Ascorbic
Vitamin Q10 (CoQ10)
22-55 390.17 223-Hydroxy-3-methylglutaric ä
Glutathione Precursor and Chelating Agent
0.17≤56 0.28 0.17N-Acetylcysteine (NAC)
Biotin (Vitamin H)
1.9-57 2.70.19 1.9Methylcitric ä
ä A high value for this marker may indicate a deficiency of this vitamin.
Organic Acids Test - Nutritional and Metabolic Profile Page 3 of 10
The Great Plains Laboratory, Inc.
Requisition #:
Patient Name:
Physician:
Date of Collection:
4/21/2015
Metabolic Markers in Urine
Reference Population - Females Age 13 and Over
(mmol/mol creatinine)
Patient
ValueReference Range
Oxalate Metabolites4.6
-
19
7.00.77
4.6
Glyceric
46
-
20
11716
46
Glycolic
69
-
21
1016.8
69
Oxalic
Glycolytic Cycle Metabolites12
≤
22
48
12
Lactic
4.4
≤
23
9.1
4.4
Pyruvic
Mitochondrial Markers - Krebs Cycle Metabolites
5.3
≤
24
9.3
5.3
Succinic
0.51
≤
25
0.94
0.51
Fumaric
0.95
-
26
1.80.06
0.95
Malic
49
≤H
27
35
49
2-Oxoglutaric18
-
28
286.8
18
Aconitic
706
≤H
29
507
706
Citric
Mitochondrial Markers - Amino Acid Metabolites
0.35
≤
30
0.76
0.35
3-Methylglutaric8.8
≤H
31
6.2
8.8
3-Hydroxyglutaric2.2
≤
32
4.5
2.2
3-Methylglutaconic
Neurotransmitter Metabolites
Phenylalanine and Tyrosine Metabolites3.3
-
33
3.60.80
(dopamine)
3.3
Homovanillic (HVA) 2.0
-
34
3.70.46
(norepinephrine, epinephrine)
2.0
Vanillylmandelic (VMA) 1.6
-
35
1.80.16
1.6
HVA / VMA Ratio
Tryptophan Metabolites
1.5
≤
36
4.3
(serotonin)
1.5
5-Hydroxyindoleacetic (5-HIAA) 2.4
-
37
3.90.85
2.4
Quinolinic
1.4
-
38
2.20.17
1.4
Kynurenic
1.6
-
39
2.00.42
1.6
Quinolinic / 5-HIAA Ratio Organic Acids Test - Nutritional and Metabolic Profile
Page 2 of 10
Requisition #:
Patient Name:
Physician:
Date of Collection:
Patient Age:F
52
Patient Sex:
Time of Collection:
Print Date:
4/21/2015
04:30 AM
04/29/2015
Metabolic Markers in Urine
Reference Population - Females Age 13 and Over
(mmol/mol creatinine)
Patient
ValueReference Range
Intestinal Microbial Overgrowth
Yeast and Fungal Markers
0.90
≤
1
3.6
0.90
Citramalic
5.4
≤
2
14
5.4
5-Hydroxymethyl-2-furoic 0
≤
3
0.33
0.00
3-Oxoglutaric
10
≤
4
16
10
Furan-2,5-dicarboxylic 0.88
≤
5
1.9
0.88
Furancarbonylglycine 1.5
≤
6
4.5
1.5
Tartaric
88
≤H
7
29
88
Arabinose
0.36
≤
8
29
0.36
Carboxycitric
0.33
≤
9
0.44
0.33
Tricarballylic
Bacterial Markers
622
≤H
10
613
622
Hippuric
0.55
-
11
0.660.06
0.55
2-Hydroxyphenylacetic1.0
≤
12
1.3
1.0
4-Hydroxybenzoic8.2
-
13
170.79
8.2
4-Hydroxyhippuric0.21
≤
14
0.38
0.21
DHPPA (Beneficial Bacteria)
Clostridia Bacterial Markers
25
≤H
15
19
(C. difficile, C. stricklandii, C. lituseburense & others)
25
4-Hydroxyphenylacetic 271
≤H
16
208
(C. sporogenes, C. caloritolerans, C. botulinum & others)
271
HPHPA
42
≤
17
75
(C. difficile)
42
4-Cresol
2.8
≤
18
11
(C. stricklandii, C. lituseburense, C. subterminale & others)
2.8
3-Indoleacetic
Testing performed by The Great Plains Laboratory, Inc., Lenexa, Kansas. The Great Plains Laboratory has developed and determined the
performance characteristics of this test. This test has not been evaluated by the U.S. FDA; the FDA does not currently regulate such testing.
Organic Acids Test - Nutritional and Metabolic ProfilePage 1 of 10
Functional & Integrative Medicine Ltd, 77 Austin St, PO Box 19033, Onekawa, Napier 4146, NZPh 0800 439 633 Fax 0800 439 630 [email protected] www.fxmed.co.nz
Please call our Technical Support Team on 0800 439 633 if you have further questions or email [email protected]